Tag: Drugs

Market pressure seen as fueling too much weight loss in new obesity drugs

Eli Lilly's next-generation obesity drug, known as retatrutide, is causing unexpected outcomes in ongoing trials. Instead of struggling

Dr. Oz, muscle supplements, weight loss drugs

Oz will give up to run CMS Dr. Mehmet Oz, the celebrity doctor and former host of "The

‘Will Cause So Much Pain’: Dem Senator Melts Down as RFK Jr. Investigates Risks of SSRI’s and Weight Loss Drugs |

After less than a week in office, Robert F. Kennedy Jr. has already stirred up controversy among Democratic

Insurer Denies Access To Drugs Granted Accelerated Approval By FDA

Health insurers have recently come under scrutiny for their decision to reject coverage of prescription drugs licensed under

Imposing Duties to Address the Flow of Illicit Drugs Across Our National Border – The White House

The President of the United States, Donald J. Trump, has declared a national emergency to address the influx

RFK Jr. says U.S. won’t use march-in rights for expensive drugs

Robert F. Kennedy Jr., President Trump's nominee to lead the Department of Health and Human Services, recently addressed

Ozempic-Like Drugs May Hold Risks For Surgical Patients, Officials Say

Officials in the United Kingdom have issued a warning regarding the potential risks associated with popular weight-loss medications

GLP-1 drugs carry wide variety of risks, benefits beyond weight loss

GLP-1 drugs like Ozempic have become incredibly popular for their effectiveness in treating diabetes and promoting weight loss.

Selection Of 15 Drugs For Price Negotiation Puts Spotlight On IRA

Medicare officials made an important announcement on January 17, 2025, revealing the next batch of 15 prescription drugs

Life-saving drugs stolen from rescue helicopter – police

Thieves have committed a heinous act by stealing crucial medicine from an Otago Southland rescue helicopter over the

GLP-1 Drugs For Weight Loss Aren’t Cost-Saving Yet

This trend of non-persistence with weight loss drugs adds another layer of complexity to the cost-effectiveness of GLP-1